Rising adoption of minimally invasive surgeries, and the growing aging population are projected to fuel the growth of the global cheek augmentation market at a CAGR of 7.8% during the forecast period 2023 to 2030

Market Research Future (MRFR) has published a cooked research report on the “global Cheek Augmentation Market” that contains information from 2023 to 2030.

Market Highlights

The global cheek augmentation market is accounted to register a CAGR of 7.8% during the forecast period and is estimated to reach USD 6.97 billion by 2030.

Cheek augmentation is a type of cosmetic surgery that emphasizes the cheeks on a person's face. The American Society of Plastic Surgeons reports that in 2020, 108,189 people, mostly women, underwent cheek implants. Additionally, 108,189 male cheek implant surgeries were performed. Additionally, there were approximately 216,350 and 28,638 facelift procedures on men and women, respectively, in 2020.

The increasing demand for cosmetic procedure, the rising adoption of minimally invasive surgeries, and the growing aging population are propelling the market growth. However, the high cost of cheek augmentation procedures is expected to hamper the growth of the global market. Nevertheless, the adoption of technological advancements in cheek augmentation market is projected to create lucrative opportunities for market players.

Key Players

MRFR recognizes the following companies as the key players in the global cheek augmentation market— AbbVie Inc (US), Merz Pharma (Germany), GALDERMA (Switzerland), Sientra, Inc (US), Stryker (US), Sinclair (UK), Johnson & Johnson Services, Inc (US), Anika Therapeutics, Inc (US), Hanson Medical Inc (US), and Zimmer Biomet (US).

Segment Analysis

The global cheek augmentation market has been segmented based on the product, technique, and end user.

On the basis of product, the market is segmented into derma fillers, implant, and others. Further, the implant segment is bifurcated into malar, submalar, and combined. The derma fillers segment was attributed to holding the largest market share in 2022.

Based on technique, the global cheek augmentation market has been segmented into surgical and non-surgical. The non-surgical segment was expected to hold the largest market share in 2022.

On the basis of the end user, the market is segmented into hospitals and clinics, ambulatory surgical centers (ASCs), and specialty clinics. The hospitals and clinics segment is projected to have the largest market share during the forecast period.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Cheek Augmentation Market Research Report

Regional Analysis

The global cheek augmentation market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America consists of US and Canada. The Europe cheek augmentation market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The cheek augmentation market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the world cheek augmentation market comprises of Middle East, Africa, and Latin America.

The high technological advances, rising demand for cosmetic procedures, growing developments in healthcare infrastructure, and rising geriatric population, are boosting the growth of the North American region. According to the American Society of Plastic Surgeons, Plastic Surgery Statistics Report 2020, 2.3 million cosmetic surgical treatments, 13.2 million cosmetic minimally invasive procedures, and 6.8 million reconstructive procedures were carried out in the world in 2020. Furthermore, increasing healthcare spending and technical developments in cosmetic operations are largely driving regional market expansion.

Moreover, the Europe market has been persistently growing owing to a high geriatric population share,   increased disposable income, changing lifestyles, and the expansion of the fashion and modeling industries in the region.

Additionally, market factors, such as high untapped opportunity, rising patient awareness levels, and economic development in the cheek augmentation market in the Asia-Pacific region are driving the region’s growth.

Furthermore, the rest of the world's cheek augmentation market is divided into the Middle East, Africa, and Latin America. The main factors influencing the growth of cheek augmentation in the Middle East and Africa are the increase in the personal and beauty industries across the major nations. In addition, governments in this region are also investing heavily in R&D activities to develop new and innovative products for cheek augmentation in the region. Additionally, it is projected that factors such as the region's aging population, increased disposable income, and changing lifestyles will contribute to the market's expansion.

Key Findings of the Study

• The global cheek augmentation market is expected to reach USD 6.97 billion by 2030, at a CAGR of 7.8% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market, owing to the high untapped opportunity, rising patient awareness levels, and economic development in the Asia-Pacific region.


• Based on technique, the non-surgical segment was attributed to holding the largest market in 2022, with an approximate market share of 45–65%.


• AbbVie Inc (US), Merz Pharma (Germany), GALDERMA (Switzerland), Sientra, Inc (US), Stryker (US), Sinclair (UK), Johnson & Johnson Services, Inc (US), Anika Therapeutics, Inc (US), Hanson Medical Inc (US), and Zimmer Biomet (US) are the key market players.